Bonfa E - Search Results

1

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, Esposto A, García MA, Catoggio LJ, Cardiel MH, Barile LA, Amigo MC, Sato EI, Bonfa E, Borba E, Lavras Costallat LT, Neira OJ, Massardo L, Guibert-Toledano M, Chacón-Díaz R, Alarcón GS, Pons-Estel BA. Pimentel-Quiroz VR, et al. Among authors: bonfa e. Lupus. 2019 Aug;28(9):1101-1110. doi: 10.1177/0961203319860579. Epub 2019 Jul 10. Lupus. 2019. PMID: 31291843

2

[Systemic lupus erythematosus in the aged: clinical and laboratory characteristics].

Takayasu V, Bonfá E, Levy Neto M, Kumeda C, Daud RM, Cossermelli W. Takayasu V, et al. Among authors: bonfa e. Rev Hosp Clin Fac Med Sao Paulo. 1992 Jan-Feb;47(1):6-9. Rev Hosp Clin Fac Med Sao Paulo. 1992. PMID: 1307405 Portuguese.

3

Lipoprotein(a) levels in systemic lupus erythematosus.

Borba EF, Santos RD, Bonfa E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhão RC. Borba EF, et al. Among authors: bonfa e. J Rheumatol. 1994 Feb;21(2):220-3. J Rheumatol. 1994. PMID: 8182628

4

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

Borba EF, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 1997;6(6):533-9. doi: 10.1177/096120339700600610. Lupus. 1997. PMID: 9256312

5

Chylomicron metabolism is markedly altered in systemic lupus erythematosus.

Borba EF, Bonfá E, Vinagre CG, Ramires JA, Maranhão RC. Borba EF, et al. Among authors: bonfa e. Arthritis Rheum. 2000 May;43(5):1033-40. doi: 10.1002/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B. Arthritis Rheum. 2000. PMID: 10817556 Free article.

6

Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.

Borba EF, Bonfá E. Borba EF, et al. Among authors: bonfa e. J Rheumatol. 2001 Apr;28(4):780-5. J Rheumatol. 2001. PMID: 11327250

7

Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations.

Pasoto SG, Mendonça BB, Bonfá E. Pasoto SG, et al. Among authors: bonfa e. Lupus. 2002;11(3):175-80. doi: 10.1191/0961203302lu163oa. Lupus. 2002. PMID: 11999882

8

Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.

Borba EF, Turrini-Filho JR, Kuruma KA, Bertola C, Pedalini ME, Lorenzi MC, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 2004;13(4):223-7. doi: 10.1191/0961203304lu528oa. Lupus. 2004. PMID: 15176656

9

The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus.

Hayata AL, Borba EF, Bonfá E, Kochen JA, Goldenstein-Schainberg C. Hayata AL, et al. Among authors: bonfa e. Lupus. 2005;14(8):613-7. doi: 10.1191/0961203305lu2177oa. Lupus. 2005. PMID: 16175933

10

Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis.

Shinzato MM, Bueno C, Trindade Viana VS, Borba EF, Gonçalves CR, Bonfá E. Shinzato MM, et al. Among authors: bonfa e. Lupus. 2005;14(12):953-8. doi: 10.1191/0961203305lu2252oa. Lupus. 2005. PMID: 16425575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters